Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Ophthalmology
•
Cornea and External Disease
•
Uveitis and Ocular Immunology
How do approach perioperative steroids for a quiescent uveitis patient undergoing cataract surgery?
Related Questions
How would you approach the management of dry corneal melt in a patient requiring high dose systemic steroids and no apparent underlying systemic autoimmune disease?
Would you consider using a JAK inhibitor for a patient with RA associated scleritis?
How do you manage Cancer-Associated Retinopathy (CAR) in a patient who doesn’t have a known cancer diagnosis, given the difficulty in finding the underlying cancer and the risks of using immunosuppressive treatments to preserve vision?
What factors should be considered when deciding whether to perform corneal crosslinking (CXL) in mild cases of keratoconus?
When should mitomycin intravascular chemoembolization be considered as a treatment for corneal neovascularization?
What factors influence your decision to pursue surgical management in cases of infectious keratitis caused by multidrug-resistant pathogens?
How do you differentiate between ocular involvement due to active tuberculosis versus latent infection in a patient with uveitis and suspected tuberculosis?
In a patient with isolated HLA B27+ anterior uveitis, how long would you continue immunosuppressive therapy?
How do you manage macular-threatening toxoplasma chorioretinitis in pregnancy?
When would you consider discontinuing immunosuppressive treatment in a quiescent uveitis patient without systemic manifestations of inflammation?
